Pasithea Therapeutics CORP. (KTTAW) SEC Filings — 2024

Filings

• Pasithea Therapeutics Files 8-K with Material Agreement — 8-K · Nov 26, 2024
• Pasithea Therapeutics CORP. SC 13G Filing — SC 13G · Nov 14, 2024
• Pasithea Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Pasithea Therapeutics Files 8-K for Equity Sales — 8-K · Sep 30, 2024
• Pasithea Therapeutics Files 8-K — 8-K · Sep 26, 2024
• Pasithea Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
• Pasithea Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 26, 2024
• Pasithea Therapeutics Files Proxy Statement — DEF 14A · May 28, 2024
• Pasithea Therapeutics Corp. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 14, 2024
• Pasithea Therapeutics Corp. Files 2023 Annual Report on Form 10-K — 10-K · Mar 29, 2024
• Pasithea Therapeutics Confirms Nasdaq Listing in 8-K Filing — 8-K · Jan 18, 2024
• Pasithea Therapeutics: Material Rights Modification for Stock & Warrants — 8-K · Jan 2, 2024